Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 6/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10069425 | 1.00 | NAAA (0.47) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL12192026 | 1.00 | NAAA (0.47) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL14409956 | 1.00 | NAAA (0.47) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL12191365 | 0.93 | ALDH1A1 (0.45) | NAAAEPHX1TSHRHCAR2ALDH1A1 | |
| SCHEMBL19910947 | 0.88 | NAAA (0.40) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL14621274 | 0.87 | NAAA (0.44) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL18638547 | 0.87 | NAAA (0.44) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL23102164 | 0.86 | ALDH1A1 (0.42) | NAAAEPHX1TSHRALDH1A1LMNA | |
| SCHEMBL10069404 | 0.85 | HCAR2 (0.34) | TSHRHCAR2ALDH1A1LMNA | |
| SCHEMBL13446195 | 0.84 | NAAA (0.48) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2006738-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-20170090283-A1 | PHOTORESIST COMPOSITIONS AND METHODS | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2017-03-30 | — | — | US | disclosed |
| EP-2792665-B1 | LIQUID REPELLENT COMPOSITION, LIQUID REPELLENT POLYMER, CURABLE COMPOSITION, COATING COMPOSITION, ARTICLE HAVING CURED FILM, ARTICLE HAVING PATTERN OF LIQUID-PHILIC REGION AND LIQUID REPELLENT REGION, AND PROCESS FOR PRODUCING IT | ASAHI GLASS CO LTD (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2792665-A1 | LIQUID REPELLENT COMPOUND, LIQUID REPELLENT POLYMER, CURABLE COMPOSITION, COATING COMPOSITION, ARTICLE HAVING CURED FILM, ARTICLE HAVING PATTERN WITH LYOPHILIC REGION AND LIQUID REPELLENT REGION, AND METHOD FOR PRODUCING SAME | Asahi Glass Company, Limited (JP) | 2014-10-22 | — | — | EP | disclosed |
| EP-2105440-B1 | Actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method using the same, polymerizable compound and polymer compound obtained by polymerizing the polymerizable compound | FUJIFILM CORP (JP) | 2012-10-24 | — | — | EP | disclosed |
| EP-2423748-A1 | Lithographic printing plate precursor and plate making method thereof | Fujifilm Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120003583-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20090011362-A1 | PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20080206668-A1 | NEGATIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170090283-A1 | PHOTORESIST COMPOSITIONS AND METHODS | PARG, PNN, PARN | NAAA 563/4885EPHX1 3934/4885TSHR 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.